Come up with a name for your new list and we'll add to it:
KAHR Medical raised a round of funding on January 28, 2009. Investors include
Hadasit Bio Holdings.
KAHR Medical is an Israeli biotech company developing a drug platform known as DSP (Dual Signaling Proteins), bi-functional fusion proteins that are based on the TNF-superfamily, the proteins that con…